<?xml version="1.0" encoding="UTF-8"?>
<XML><RECORDS>
<RECORD>
	<REFERENCE_TYPE>0</REFERENCE_TYPE>
	<AUTHORS>
		<AUTHOR>LILLEY, JC</AUTHOR>
		<AUTHOR>PATTERSON, LH</AUTHOR>
		<AUTHOR>TAYLOR, MJ</AUTHOR>
	</AUTHORS>
	<YEAR>1994</YEAR>
	<TITLE>PREPARATION AND STABILITY OF LIPOSOME-ENCAPSULATED DOXORUBICIN AND
   MITOXANTRONE AND THEIR INTERNALIZATION BY MURINE PERITONEAL-MACROPHAGES</TITLE>
	<SECONDARY_TITLE>INTERNATIONAL JOURNAL OF PHARMACEUTICS</SECONDARY_TITLE>
	<VOLUME>107</VOLUME>
	<PAGES>149-157</PAGES>
	<DATE>JUL 4</DATE>
	<ABSTRACT>Liposomal encapsulation of the cytotoxic drugs doxorubicin or
   mitoxantrone was achieved with a lipid combination of 10:1:10
   DPPC/DPPG/cholesterol. Both drugs were observed, by confocal
   fluorescence microscopy, to be almost entirely associated with the
   liposome bilayers. A method is described for loading of macrophages
   intraperitoneally with liposome encapsulated doxorubicin or
   mitoxantrone and the subsequent isolation of viable macrophages (83.5
   +/- 6.6\%) using a separative technique based on Ficoll and Percoll.
   Confocal microscopy also revealed that the intact liposomes were
   internalised in macrophages and that liposomal drug was located in
   phagosomes. By comparison the free drug was located, in the case of
   both mitoxantrone and doxorubicin, around the periphery of the nucleus.
   No intracellular leakage of mitoxantrone from the liposomes after
   internalisation by the murine peritoneal macrophages was observed
   whilst some leakage was apparent for doxorubicin.</ABSTRACT>
</RECORD>
</RECORDS></XML>
